The U.S. Software as a Medical Device (SaMD) market was valued at USD 2.1 billion in 2023 and is projected to reach USD 8.4 billion by 2032, growing at a CAGR of 16.5% (2024–2032). The growth is driven by the rise in AI- and ML-powered healthcare applications, increasing adoption of digital therapeutics (DTx), and a strong regulatory framework from the U.S. FDA supporting innovation in...
0 Commentarios
0 Acciones
214 Views
0 Vista previa
The North America interventional cardiology market was valued at USD 7.2 billion in 2023 and is projected to reach USD 11.9 billion by 2032, growing at a CAGR of 5.7% (2024–2032). Growth is fueled by the high prevalence of cardiovascular diseases (CVDs), increasing demand for minimally invasive cardiac procedures, and the adoption of advanced stents, catheters, and imaging systems.
📌...
0 Commentarios
0 Acciones
263 Views
0 Vista previa
The global mammography machine market was valued at USD 2.3 billion in 2023 and is expected to reach USD 4.1 billion by 2032, growing at a CAGR of 6.4% during 2024–2032. Growth is fueled by the rising prevalence of breast cancer, growing adoption of early screening programs, and advancements in digital breast tomosynthesis (DBT) and AI-powered mammography systems.
📌 Download a free sample...
0 Commentarios
0 Acciones
263 Views
0 Vista previa
The global electroretinography (ERG) market was valued at USD 42.5 million in 2023 and is projected to reach USD 72.8 million by 2032, growing at a CAGR of 6.1% during 2024–2032. Growth is driven by the rising prevalence of retinal disorders, increasing demand for early ophthalmic disease diagnosis, and technological advancements in portable and multifocal ERG devices.
📌 Download a free...
0 Commentarios
0 Acciones
270 Views
0 Vista previa
The global gene transfer technologies market was valued at USD 4.6 billion in 2023 and is projected to reach USD 11.8 billion by 2032, growing at a CAGR of 11.2% during 2024–2032. Growth is driven by the rising prevalence of genetic disorders, advancements in cell & gene therapy, increasing investment in biopharmaceutical R&D, and the growing application of viral and non-viral...
0 Commentarios
0 Acciones
205 Views
0 Vista previa
The global rheometer and viscometer market reached USD 1.7 billion in 2023 and is projected to grow to USD 3.2 billion by 2032, expanding at a CAGR of 7.2% during 2024–2032. Growth is driven by rising demand for material characterization in industries such as pharmaceuticals, food & beverages, chemicals, petrochemicals, and polymers, alongside technological advancements in digital and...
0 Commentarios
0 Acciones
231 Views
0 Vista previa
The global intraoral radiography market reached USD 2.9 billion in 2023 and is projected to grow to USD 5.4 billion by 2032, expanding at a CAGR of 7.1% during 2024–2032. Growth is fueled by rising prevalence of dental disorders, increasing demand for cosmetic dentistry, advancements in digital X-ray technology, and growing awareness of oral health. Transition from analog to digital...
0 Commentarios
0 Acciones
211 Views
0 Vista previa
The global interventional imaging market reached USD 6.8 billion in 2023 and is projected to grow to USD 12.5 billion by 2032, expanding at a CAGR of 7.2% during 2024–2032. The market is driven by rising demand for minimally invasive procedures, technological advancements in imaging modalities, and increasing prevalence of cardiovascular diseases, cancers, and neurological disorders....
0 Commentarios
0 Acciones
207 Views
0 Vista previa
The Asia-Pacific digital pathology market reached USD 290 million in 2023 and is projected to grow to USD 730 million by 2032, expanding at a CAGR of 10.8% during 2024–2032. Growth is driven by the rising cancer burden, government healthcare modernization programs, rapid adoption of telemedicine, and increasing investment in AI-powered diagnostic technologies. The surge in clinical...
0 Commentarios
0 Acciones
214 Views
0 Vista previa
The Europe digital pathology market reached USD 375 million in 2023 and is projected to grow to USD 820 million by 2032, expanding at a CAGR of 9.2% during 2024–2032. Growth is being driven by rising cancer prevalence, government-led healthcare digitization programs, and the increasing adoption of AI-enabled diagnostic tools. The surge in demand for telepathology and cross-border medical...
0 Commentarios
0 Acciones
220 Views
0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek